Search This Blog

Tuesday, January 26, 2021

NOVARTIS AG Gets a Buy rating from UBS

 In a research note published by Laura Sutcliffe, UBS advises its customers to buy the stock. The target price remains unchanged at CHF 96.

https://www.marketscreener.com/quote/stock/NOVARTIS-AG-9364983/news/NOVARTIS-AG-Gets-a-Buy-rating-from-UBS-32276875/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.